Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response

被引:0
|
作者
Vansteenkiste, JF [1 ]
Colowick, AB
机构
[1] Univ Hosp Gasthuisberg, Resp Oncol Unit Pulmonol, B-3000 Louvain, Belgium
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1093/jnci/95.10.762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:762 / 763
页数:2
相关论文
共 50 条
  • [41] Randomized double-blind placebo-controlled trial evaluating pregabalin for chronic cough in patients with lung cancer.
    Noronha, Vanita
    Menon, Nandini Sharrel
    Patil, Vijay Maruti
    Shah, Minit Jalan
    Joshi, Amit
    Jain, Srushti
    Nawale, Kavita Prakash
    Surve, Rohan
    Bafna, Gunj
    Jogdhankar, Shweta
    Shelar, Priyanka
    Singh, Ashish
    Salian, Sushmita
    Jadhav, Pundlik
    Shah, Hetakshi
    Mer, Neha Jagdish
    Vohra, Ananya
    Majumdar, Swaratika
    Badwe, Rajendra A.
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA12082 - LBA12082
  • [42] Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial
    Radhakrishnan, Venkatraman
    Joshi, Archit
    Ramamoorthy, Jaikumar
    Rajaraman, Swaminathan
    Ganesan, Prasanth
    Ganesan, Trivadi S.
    Dhanushkodi, Manikandan
    Sagar, Tenali G.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (03)
  • [43] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [44] A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: A URCC CCOP Study
    Morrow, G. R.
    Jean-Pierre, P.
    Roscoe, J. A.
    Heckler, C. E.
    Schwartzenberger, P. O.
    Giguere, J. K.
    Dakhil, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [46] Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors
    Rapp, Stephen R.
    Case, Doug
    Peiffer, Ann
    Naughton, Michelle Joy
    Stieber, Volker W.
    Bayer, Gerald K.
    Bilodeau, Paul A.
    Moore, Dennis Frederic
    Falchuk, Steven Charles
    Needles, Burton M.
    Piephoff, James
    Edenfield, William J.
    Giguere, Jeffrey K.
    Erickson, Nicholette
    Loghin, Monica Elena
    Shaw, Edward G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy
    Saadipoor, Afshin
    Razzaghdoust, Abolfazl
    Simforoosh, Nasser
    Mahdavi, Arash
    Bakhshandeh, Mohsen
    Moghadam, Maryam
    Abdollahi, Hamid
    Mofid, Bahram
    PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 370 - 378
  • [48] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [49] A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
    Uchio, Yuji
    Enomoto, Hiroyuki
    Alev, Levent
    Kato, Yuki
    Ishihara, Hiroyuki
    Tsuji, Toshinaga
    Ochiai, Toshimitsu
    Konno, Shinichi
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 809 - 821
  • [50] Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial
    Umezawa, Yoshinori
    Nakagawa, Hidemi
    Tamaki, Kunihiko
    JOURNAL OF DERMATOLOGY, 2016, 43 (03): : 288 - 293